Details of the Drug Reposition

General Information of This Drug (ID: DMXQEAA)

Drug Name
IGF-MTX   DMXQEAA

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 1/2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Chronic myelogenous leukaemia DIS0301E 2A20.0 Phase 1/2 [1]
Myelodysplastic syndrome DISYHNUI 2A37 Phase 1/2 [1]
------------------------------------------------------------------------------------
1 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Solid tumour/cancer DISZR48F 2A00-2F9Z Phase 1 [2]
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 ClinicalTrials.gov (NCT02045368) Study of IGF-Methotrexate Conjugate in the Treatment of Advanced Tumors Expressing IGF-1R. U.S. National Institutes of Health.